The value of the Ethos in the context of COVID-19

Published on: 17 April 2020

Resources

IFPMA President David Ricks on Global Pledge Committing to Work Together to Beat COVID-19 (Video)
Videos

Videos

IFPMA President David Ricks on Global Pledge Committing to Work Together to Beat COVID-19 (Video)

IFPMA remarks on intellectual property management and the global response to COVID-19
Statements

Statements

IFPMA remarks on intellectual property management and the global response to COVID-19

Pharma CEO/Top Executives Global Response to COVID-19 – Virtual Press Briefing – 19 March 2020 (Video)
Videos

Videos

Pharma CEO/Top Executives Global Response to COVID-19 – Virtual Press Briefing – 19 March 2020 (Video)

Global Biopharmaceutical Industry Commitment to Address Coronavirus Public Health Crisis
Statements

Statements

Global Biopharmaceutical Industry Commitment to Address Coronavirus Public Health Crisis

Global Biopharmaceutical Industry pulling out all the stops to address Coronavirus public health crisis
News Releases

News Releases

Global Biopharmaceutical Industry pulling out all the stops to address Coronavirus public health crisis

Global Pharma update on unprecedented efforts to collaborate in speeding up the search for safe and effective COVID-19 therapies
News Releases

News Releases

Global Pharma update on unprecedented efforts to collaborate in speeding up the search for safe and effective COVID-19 therapies

IFPMA Members’ support in countering the novel coronavirus (2019-nCoV)
Statements

Statements

IFPMA Members’ support in countering the novel coronavirus (2019-nCoV)

IFPMA Code of Practice 2019
Publications

Publications

IFPMA Code of Practice 2019

IFPMA Code of Practice 2019 – Our Ethos
Publications

Publications

IFPMA Code of Practice 2019 – Our Ethos

Innovative health industries united in welcoming United Nations General Assembly Resolution on “International Cooperation to ensure global access to medicines, vaccines and medical equipment to face COVID-19″
Statements

Statements

Innovative health industries united in welcoming United Nations General Assembly Resolution on “International Cooperation to ensure global access to medicines, vaccines and medical equipment to face COVID-19″

IFPMA Statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools
Statements

Statements

IFPMA Statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools

Pharma industry body joins as founding partner a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools
News Releases

News Releases

Pharma industry body joins as founding partner a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools

Related Blog Entries

Supporting the global collaboration initiative to accelerate the development, production and equitable access to new COVID-19 tools

Supporting the global collaboration initiative to accelerate the development, production and equitable access to new COVID-19 tools

Interview – BBC World Newshour – Biopharmaceutical industry commitments on COVID-19

Interview – BBC World Newshour – Biopharmaceutical industry commitments on COVID-19

5 Questions to …. five leading biopharmaceutical company CEOs and top executives on the COVID-19 Pandemic

5 Questions to …. five leading biopharmaceutical company CEOs and top executives on the COVID-19 Pandemic

Related Links

Novel coronavirus 2019-nCoV exposes a flaw in the Nagoya Protocol
Novel Coronavirus (COVID-19)
Access to COVID-19 Tools (act) Accelerator

Related Topics

COVID-19

Tags